Dr. Anthony Sedgwick joins DotBio as Strategy Advisor

Dr. Sedgwick brings more than 32 years of experience in the pharmaceutical industry. He was previously the CEO of four biotechnology companies and a Senior Executive at Roche Pharmaceuticals. Dr. Sedgwick has held many Board and Chair positions in several UK and European Biotech and Pharma companies.

25 JAN 2019

6 JAN 2019

DotBio attends China Focus and Biotech Showcase at JPM2019, San Francisco

5 JAN 2019

DotBio launches its Hong Kong subsidiary, DotBioHK Limited

DotBio launched DotBioHK at Hong Kong’s Science and Technology Park. The subsidiary, which currently has 3 employees, will focus on partnerships and new opportunities in the China market.

26 DEC 2018

DotBio secures SGD 250,000 from Enterprise Singapore 

DotBio secured SGD 250,000 in non-dilutive funding from Enterprise Singapore’s SSG-Tech proof-of-concept grant. The grant will allow DotBio to validate some of our bi-specific DotBodies further, strengthen our IP strategy, and expand our team.

10 DEC 2018

DotBio presents at the 4th Annual Peptides and Proteins Symposium, Singapore

1 NOV 2018

DotBio attends the Biotech Investment Summit, Singapore

17 OCT 2018


DotBio presents the company and latest updates at the 2018 BIO Investor Forum, happening on October 17-18, 2018 in San Francisco.

5 SEP 2018

DotBio announces new advisors

Dr. Bertil Lindmark and Dr. Dineli Wickramasinghe join DotBio as scientific advisors.

6 AUG 2018



DotBio successfully launches to focus on next generation of immuno-oncology drugs based on domain antibodies.

12-14 Mar 2018




DotBio will be present at the BIOEUROPE SPRING 2018 in Amsterdam

DotBio will be present at BIOEUROPE SPRING 2018 in Amsterdam to search for partners to accelerate its lead and preclinical development projects.

7 Aug 2017

DotBio will be presenting at the 2017 BIO Investor Forum

DotBio will be presenting the company at the 2017 BIO Investor Forum, happening on October 17-18, 2017 in San Francisco.

6 Jun 2017

DotBio is incorporated in Singapore

DotBio was incorporated today in Singapore as a Private Limited company. The company has officially started operations and is actively looking for investors for its seed funding round.


Asial I, Cheng YX, Engman H, Dollhopf M, Wu B, Nordlund P, Cornvik T.

Engineering protein thermostability using a generic activity-independent biophysical screen inside the cell. Nature Communications. 2013; 4: 2901.